Association of Pretreatment Neutrophil-to-Eosinophil Ratio with Clinical Outcomes in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab

BACKGROUND: There is a need to develop biomarkers for a more efficient use of immune checkpoint inhibitors (ICIs). Recently, it has been reported that peripheral blood components, including eosinophils, may be effective ICI biomarkers. This study was designed to evaluate the prognostic value of eosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Shinsuke, Abe, Tomoe, Endo, Tentaro, Kaya, Haruka, Kitabayashi, Takuro, Kawasaki, Yohei, Yamada, Takechiyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704394/
https://www.ncbi.nlm.nih.gov/pubmed/36452436
http://dx.doi.org/10.2147/CMAR.S382771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704394/
https://www.ncbi.nlm.nih.gov/pubmed/36452436
http://dx.doi.org/10.2147/CMAR.S382771

Ejemplares similares